Gastroenterology and Digestive Disease Treatment at Asan Medical Center in Seoul, South Korea
Only hospital in Korea certified as a World Endoscopy Organisation Centre of Excellence, ranked World No. 4 in Gastroenterology by Newsweek 2026.
Why Choose Asan for Liver and Digestive Disease Treatment Abroad
2.25M+ endoscopic procedures, treating liver cancer, IBD, gastric cancer, biliary disease and more.
Gastroenterologists, hepatologists, gastrointestinal surgeons, oncologists, radiologists, and pathologists with dedicated centres for liver diseases, IBD, gastric cancer, and biliary cancer.
- Newsweek World No. 4 in Gastroenterology, 2026.
- Korea's only WEO Centre of Excellence, certified three times.
- 5,400+ international gastroenterology patients from 70 countries.
- Korea's largest IBD programme: 6,000+ patients.
- 7 languages: English, Arabic, Chinese, Russian, Mongolian, Japanese, Vietnamese.
- Written second opinion in 3 to 5 business days before you travel.
- Direct billing: Bupa, Cigna, United Healthcare, Daman, AIG, and 10 more.
- Paediatric digestive care available at AMC Children's Hospital.
Digestive Disease Technology at Asan Medical Center in Seoul, South Korea
Precise endoscopic imaging and minimally invasive tools mean your digestive condition is identified accurately, treated with less disruption.
- Endoscopic Ultrasound (EUS)
- ERCP Intervention System
- Endoscopic Submucosal Dissection (ESD)
- Da Vinci Robotic Gastrointestinal Surgery
- Laparoscopic Intracorporeal Anastomosis
- 24-Hour Oesophageal pH Monitoring
- PET-CT Digestive Imaging
- Gastrointestinal Function Testing
Liver and Digestive Disease Treatments at Asan for International Patients
Each digestive disease treatment plan is matched to your diagnosis, medical history, and clinical stage
IBD Treatment
Korea's first and largest IBD programme; 6,000 patients, 40% of all IBD surgery nationally.
Inquire
Insurances Accepted
Explore insurances accepted at Asan Medical Center
AFSPA
AIG
Bupa
Cigna
Daman
Euro-Center
HTH Worldwide
MetLife
MS and AD Insurance Group
MSH International
Prestige International
Sompo Japan Nipponkoa
TieCare International
Tokio Marine Nichido
Tricare
UnitedHealthcare Global
Discover your insurance options at Asan Medical Center
Looking for a specific insurance provider? Simply use our search function or contact us for assistance and our knowledgeable team will happily verify whether your provider is accepted at our facility.
Ask about your insuranceCare Journey for International Patients
Your cancer treatment journey made simple and stress-free in 5 easy steps
-
1
Online inquiry & medical files upload Share your medical reports for review. It takes less than a minute.
-
2
Doctor review & treatment plan Within 24hrs you will receive treatment options & a preliminary plan before travel.
-
3
Travel coordination We arrange your visa, flights, and accommodation.
-
4
Treatment phase Full care under a dedicated case manager.
-
5
Start your treatment Begin treatment with full support from our care team.
Frequently Asked Questions
Have a question? Our support team is here to guide you through each step of your treatment journey with personal care and attention.Can Asan review my digestive disease reports before I travel?
Yes. Two remote options are available. Written second opinion: based on your reports and imaging, delivered within 3 to 5 business days. Video consultation: live with your local doctor and an AMC specialist, delivered within 5 to 7 business days. Records must be in English or Korean. The specialist team confirms whether travel is recommended and which treatment applies to your case.
How do I contact the gastroenterology team at Asan Medical Center?
International gastroenterology patients are coordinated through the International Healthcare Centre (IHC), which handles everything from first enquiry to post-treatment follow-up. WhatsApp: +1 718 550 0880. Telephone: +1 718 550 0880. Email: [email protected]. The coordination team manages appointments, translation, accommodation, and logistics. The gastroenterology multidisciplinary team reviews your reports and provides your treatment plan. A written second opinion is available within 3 to 5 business days without committing to travel.
How long do I need to stay in Seoul for digestive disease treatment?
Stay duration depends on your condition and procedure. ESD/EMR or ERCP: 1 to 3 days. Laparoscopic gastrectomy: 5 to 7 days inpatient, 2 to 4 weeks before flying. Colorectal cancer surgery: 5 to 7 days inpatient. Whipple or major pancreatic surgery: 10 to 14 days inpatient. IBD surgery: 5 to 10 days inpatient. TACE or RFA for liver cancer: outpatient or 1 to 2 days. Liver transplantation: 3 to 5 weeks minimum. Your coordinator confirms the full schedule and remote follow-up before you travel.
How much does gastroenterology treatment cost at Asan Medical Center?
Cost varies based on condition, procedure, length of stay, and whether oncology or radiation is required. Direct insurance billing is accepted from Bupa, Cigna, United Healthcare, Daman, AIG, and Tricare. Submit your reports for a remote review to receive an estimate before travelling.
What digestive conditions does Asan Medical Center treat internationally?
AMC treats liver cancer, gastric cancer, colorectal cancer, biliary and pancreatic disease, Crohn's disease, ulcerative colitis, and complex biliary conditions requiring ERCP. Ranked World No. 4 in Gastroenterology by Newsweek (2026) and the only WEO Centre of Excellence in Korea (one of 20 globally), AMC has treated over 5,400 international gastroenterology patients from 70 countries over the past decade.
What makes AMC's gastroenterology programme stand out in South Korea?
AMC is the only hospital in Korea to hold the WEO Centre of Excellence designation, certified three times (2015, 2021, 2025), and one of only 20 globally. Ranked World No. 4 by Newsweek (2026), it performs 7,995 ERCP procedures per year (the highest in Korea), holds the world record for living donor liver transplantation, and operates Korea's largest IBD programme with 6,000 registered patients and a 40% national surgical share.
